GSK to buy Canada's 35Pharma for $950 million
GSK to buy Canada's 35Pharma for $950 million is drawing significant interest across the industry.
GSK on Wednesday agreed to pay $950 million in cash for Canadian biopharmaceutical company 35Pharma Inc, which is developing a medicine for pulmonary hypertension.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Payments Council writes to FM Sitharaman over Fino Bank CEO’s arrest
- Lakers Hire NCAA National Championship
- New York governor rethinks climate ambitions
- Jest, a marketplace for messaging games, is challenging the app store status quo
Source: Original →